These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24621797)

  • 1. Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival.
    Smedira NG; Hoercher KJ; Lima B; Mountis MM; Starling RC; Thuita L; Schmuhl DM; Blackstone EH
    JACC Heart Fail; 2013 Feb; 1(1):31-9. PubMed ID: 24621797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis.
    Akhter SA; Badami A; Murray M; Kohmoto T; Lozonschi L; Osaki S; Lushaj EB
    Ann Thorac Surg; 2015 Sep; 100(3):884-9. PubMed ID: 26095106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Readmissions after implantation of axial flow left ventricular assist device.
    Hasin T; Marmor Y; Kremers W; Topilsky Y; Severson CJ; Schirger JA; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Stulak JM; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2013 Jan; 61(2):153-63. PubMed ID: 23219299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors determining post-operative readmissions after left ventricular assist device implantation.
    Tsiouris A; Paone G; Nemeh HW; Brewer RJ; Morgan JA
    J Heart Lung Transplant; 2014 Oct; 33(10):1041-7. PubMed ID: 25034795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unplanned hospital readmissions following HeartMate 3 implantation: Readmission rates, causes, and impact on survival.
    Shih H; Mondellini GM; Kurlansky PA; Sun J; Ning Y; Feldman VR; Tiburcio M; Maguire CW; Ladanyi A; Clerkin K; Naka Y; Sayer GT; Uriel N; Colombo PC; Takeda K; Yuzefpolskaya M
    Artif Organs; 2024 Sep; 48(9):1049-1059. PubMed ID: 38825957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital.
    Forest SJ; Bello R; Friedmann P; Casazza D; Nucci C; Shin JJ; D'Alessandro D; Stevens G; Goldstein DJ
    Ann Thorac Surg; 2013 Apr; 95(4):1276-81. PubMed ID: 23481701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better With Time: An Economic Assessment of Long-Term Mechanical Circulatory Support in a Population Surviving at Least 1 Year with a Left Ventricular Assist Device.
    Chung JJ; Stetson R; Gordon J; Chen CW; Gaffey AC; Rame JE; Acker M; Atluri P
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):738-746. PubMed ID: 30308249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thirty-Day Readmissions After Left Ventricular Assist Device Implantation in the United States: Insights From the Nationwide Readmissions Database.
    Agrawal S; Garg L; Shah M; Agarwal M; Patel B; Singh A; Garg A; Jorde UP; Kapur NK
    Circ Heart Fail; 2018 Mar; 11(3):e004628. PubMed ID: 29519902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Readmissions after continuous flow left ventricular assist device implantation.
    Kimura M; Nawata K; Kinoshita O; Yamauchi H; Hoshino Y; Hatano M; Amiya E; Kashiwa K; Endo M; Kagami Y; Nemoto M; Ono M
    J Artif Organs; 2017 Dec; 20(4):311-317. PubMed ID: 28752193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.